Allergan Asks 9th Circ. To Ignore Atty's Claims Of Fraud
By Kelly Lienhard · January 30, 2024, 6:58 PM EST
Allergan has urged the Ninth Circuit to uphold a California federal court's decision to toss a suit from a patent litigator concerning claims of fraudulently landing dementia drug patents, arguing that the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login